Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Yong Ben
Country of residence : Unknown
Linked companies : Beigene Ltd

Biography of Yong Ben 
Currently, Yong Ben holds the position of Chief Medical Officer-Immuno & Oncology Department at BeiGene Ltd. Dr. Ben received a doctorate from Norman Bethune Medical University and an MBA from the University of California San Diego.


Current positions of Yong Ben 
Yong Ben : Personal Network 
Most Read News 
10/12CATHIE WOOD : ARK Invest's Wood warns upcoming economic downturn in China 'obvious'
RE
10/15JACK DORSEY : Square CEO Dorsey says looking to build a bitcoin mining system - tweet
RE
10/11JAMIE DIMON : JPMorgan's Dimon blasts bitcoin as 'worthless', due for regulation
RE
10/20JACK MA : Alibaba founder Ma spotted in Mallorca in rare trip abroad after China scrutiny
RE
10/17ELON MUSK : Tesla's Musk dials into Volkswagen executive conference
RE
10/13WARREN BUFFETT : Buffett-backed Nubank turns a profit in Brazil
RE
10/21ALEXANDRE RICARD : Pernod Ricard 1Q Sales Soar as Drinkers Head to the Bars
DJ
10/18BILL GATES : Electric vehicle battery startup ONE backed by BMW, Gates-led firm
RE
10/22WARREN BUFFETT : Generali closer to controlling Cattolica after Buffett tenders shares - source
RE
10/20ELON MUSK : No Elon Musk Show during this Tesla quarterly call
RE
More news


© 2021 People and Ownership :   
Yong Ben : Connections 


Latest news about Yong Ben 
06/17BEIGENE : Doses First Patient in Phase 3 Trial of Lung Cancer Antibody Combo Therapy
MT
06/07BEIGENE : Announces Acceptance of Supplemental Biologics License Application for Tislelizumab in China
MT
05/21BEIGENE : Cancer Therapy Meets Primary Endpoint of Phase 3 Trial
MT
2020BEIGENE : Phase 3 Trial of Tislelizumab to Treat Lung Cancer Meets Primary Endpoint
MT
2017BioAtla, LLC Appoints Yong Ben as Chief Medical Officer
CI
More news